CDC urges wider use of meningococcal vaccine

The Centers for Disease Control and Prevention has issued new recommendations that all 11- and 12-year-old children should be immunized against meningococcal bacteria, which can cause often fatal infections. The agency urged wider use of Sanofi Pasteur's Menactra, which has been recommended for adolescents and freshmen in college. In particular, the CDC wants all college freshmen living in dorms inoculated. Meningococcal disease afflicts about 3,000 people a year and kills about one-in-10.

- read this story from The New York Times for more on the recommendation

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.